Cedarhurst

Cedarhurst, New York 11516

0 studies enrolling now · 4 studies all time

What they study most

PTSD

Studies at this site

• 12-Week Open-Label Extension Study of TNX-102 SL in PTSD Patients — Stopped early
• A 40-week Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSD — Completed
• Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions — Completed
• Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD — Stopped early